Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.

[Beijing China (Mainland) ]

  • 1st
Business Type:
Manufacturer
Year Established:
2006
Total Revenue:
US$10 Million - US$50 Million
Main Markets:
South America, Eastern Europe, Southeast Asia, Africa, Oceania, Mid East, Eastern Asia

Company Description

Lonzeal Pharmaceuticals is one of the largest manufacturers of anti-retroviral (HIV and HBV) APIs in China. Current product line covers Lamivudine, Emtricitabine, Lopinavir, Ritonavir, Zidovudine, and Nevirapine, manufactured under cGMP. The annual capacity is 100MT Lamivudine, 20MT Emtricitabine and their intermediates, with continuous export to esteemed FPP manufacturers in multi-countries such as India, Russia, Africa and South America.

The manufacturing site is GMP certified and API products comply with USP, EP and International Pharmacopeia. Lamivudine API is certified by WHO PreQualification Programme, Emtricitabine DMF is also available and already submitted to WHO and USFDA. With high quality products and most competitive price, Lonzeal would be your trusted manufacturing partner in API and intermediates!